620 results on '"Lanctôt, Krista L."'
Search Results
2. Burden of Illness in People with Alzheimer’s Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality
3. Heterogeneity of Cognition in Older Adults with Remitted Major Depressive Disorder: A Latent Profile Analysis
4. Cytochrome P450-soluble epoxide hydrolase oxylipins, depression and cognition in type 2 diabetes
5. The effect of exercise on blood concentrations of angiogenesis markers in older adults: A systematic review and meta-analysis
6. Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial
7. Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression
8. Cognitive function based on theta-gamma coupling vs. clinical diagnosis in older adults with mild cognitive impairment with or without major depressive disorder
9. Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis
10. Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis
11. Cytochrome P450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes
12. Identifying factors influencing cognitive outcomes after anodal transcranial direct current stimulation in older adults with and without cognitive impairment: A systematic review
13. Cognitive control, interference inhibition, and ordering of information during working memory in younger and older healthy adults
14. Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment: a meta-analysis
15. Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects
16. Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis
17. Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects
18. Time setting errors in the Clock Drawing Test are associated with both semantic and executive deficits.
19. Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial).
20. Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markers
21. Depression and Increased Risk of Alzheimer's Dementia: Longitudinal Analyses of Modifiable Risk and Sex-Related Factors
22. Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes
23. Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
24. The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect
25. Apathy as a Treatment Target in Alzheimer's Disease: Implications For Clinical Trials
26. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate
27. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments
28. Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition
29. Serum osteocalcin is associated with subjective stress in people with depression and type 2 diabetes
30. Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico‐pathological study.
31. Sex‐specific neuropsychological correlates of apathy and depression across neurodegenerative disorders.
32. Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer’s disease
33. Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
34. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
35. Antidepressant-placebo differences for specific adverse events in major depressive disorder: A systematic review
36. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
37. Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
38. The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment
39. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
40. Longitudinal associations between 4-hydroxynonenal and depression in coronary artery disease patients
41. The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysis
42. Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review
43. Association between clinical dementia rating and clinical outcomes in Alzheimer's disease.
44. No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes.
45. A Literature Review on the Burden of Alzheimer's Disease on Care Partners.
46. Global grey matter volume in adult bipolar patients with and without lithium treatment: A meta-analysis
47. Respiratory illness and respiratory syncytial virus hospitalization in infants with a tracheostomy following prophylaxis with palivizumab
48. Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-Analysis
49. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease
50. Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.